Abdel Kareem Azab

16PUBLICATIONS
41CO-AUTHORS
Medical mycologyMedical infection agents (incl. prions)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 13, 2026
When Myeloma Escapes the Bone Marrow: Extramedullary Disease in the Immunotherapy Era.

|Aug 30, 2024
IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma.

Jennifer Sun, Stefan Corradini, Feda Azab

|Nov 18, 2022
An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma.

Odai Darawshi, Barbara Muz, Shiri Gershon Naamat

|Jul 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma.

Ellen Weisberg, Basudev Chowdhury, Chengcheng Meng

|Jan 11, 2022
Liposomal phytohemagglutinin: In vivo T-cell activator as a novel pan-cancer immunotherapy.

Kinan Alhallak, Jennifer Sun, Barbara Muz

|May 17, 2021
3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistance.

Kinan Alhallak, Pilar de la Puente, Amanda Jeske

Pageof 3

Frequent Collaborators

4 joint publications

Barbara Muz

2 joint publications

Stefan Corradini

2 joint publications

Noha Nabil Salama

2 joint publications

Mark T S Williams